EWA EHRLICH: Open Payments
NPI 1134895196 · BERWYN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 48 payments from 10 companies in 2025. Trend: 2023 $938 · 2024 $395 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $469 |
| Teva Pharmaceuticals USA, Inc. | 13 | $211 |
| Alkermes, Inc. | 5 | $128 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Janssen Pharmaceuticals, Inc | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Corium, LLC | 1 | $13 |
Products named: VRAYLAR, UZEDY, ARISTADA, COBENFY, SPRAVATO, CAPLYTA, REXULTI, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
